findmyKOL
Clinical trialNCT00070993CompletedPhase 2Interventional

Creatine for the Treatment of Amyotrophic Lateral Sclerosis

SponsorNational Center for Complementary and Integrative Health (NCCIH)Enrollment110Amyotrophic Lateral Sclerosis
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Creatine is a naturally occurring chemical involved in the production of energy in muscle. Abnormalities in creatine have been linked to the progression of degenerative neuromuscular diseases such as amyotrophic lateral sclerosis (ALS, or Lou Gehrig's Disease). This study will test whether taking creatine can improve the symptoms of ALS.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • California Pacific Medical Center

    San Francisco, California, United States

  • Rush-Presbyterian St. Luke'S Medical Center

    Chicago, Illinois, United States

  • University of Kansas Medical Center

    Kansas City, Kansas, United States

  • University of New Mexico - Medical Center

    Albuquerque, New Mexico, United States

  • University of Texas Health and Science Center

    San Antonio, Texas, United States

  • University of Virginia Health System

    Charlottesville, Virginia, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Creatine
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Dec 2002
Primary completion
—
Completion
31 May 2006
Last update posted
4 Aug 2006
Registered enrollment
110
Registry id
NCT00070993
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.